J9311
HCPCSInj rituximab, hyaluronidase
Official HCPCS Level II long descriptor
Injection, rituximab 10 mg and hyaluronidase
HCPCS Level II code J9311 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Inj rituximab, hyaluronidase
Added to HCPCS: 2019-01-01
Nearby codes in J9
- J9302Ofatumumab injection
- J9303Panitumumab injection
- J9304Inj. pemetrexed, 10 mg
- J9305Inj. pemetrexed nos 10mg
- J9306Injection, pertuzumab, 1 mg
- J9307Pralatrexate injection
- J9308Injection, ramucirumab
- J9309Inj, polatuzumab vedotin 1mg
- J9312Inj., rituximab, 10 mg
- J9313Inj., lumoxiti, 0.01 mg
- J9314Inj pemetrexed (teva) 10mg
- J9316Pertuzu, trastuzu, 10 mg
- J9317Sacituzumab govitecan-hziy
- J9318Inj romidepsin non-lyo 0.1mg
- J9319Inj romidepsin lyophil 0.1mg
- J9320Streptozocin injection
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.